Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun 24;27 Suppl 2(4):B64-70.
doi: 10.1016/j.vaccine.2009.04.061. Epub 2009 May 21.

Meningococcal carriage and disease--population biology and evolution

Affiliations
Review

Meningococcal carriage and disease--population biology and evolution

Dominique A Caugant et al. Vaccine. .

Abstract

Meningococcal disease occurs worldwide with incidence rates varying from 1 to 1000 cases per 100,000. The causative organism, Neisseria meningitidis, is an obligate commensal of humans, which normally colonizes the mucosa of the upper respiratory tract without causing invasive disease, a phenomenon known as carriage. Studies using molecular methods have demonstrated the extensive genetic diversity of meningocococci isolated from carriers, in contrast to a limited number of genetic types, known as the hyperinvasive lineages, associated with invasive disease. Population and evolutionary models that invoke positive selection can be used to resolve the apparent paradox of virulent lineages persisting during the global spread of a non-clonal and normally commensal bacterium. The application of insights gained from studies of meningococcal population biology and evolution is important in understanding the spread of disease, as well as in vaccine development and implementation, especially with regard to the challenge of producing comprehensive vaccines based on sub-capsular antigens and measuring their effectiveness.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Griffiss J.M., Brandt B., Jarvis G.A. Natural immunity to Neisseria meningitidis. In: Vedros N.A., editor. vol. II. CRC Press; Boca Raton: 1987. pp. 99–119. (Evolution of meningococcal disease).
    1. de Voe I.W. The meningococcus and mechanisms of pathogenicity. Microbiol Rev. 1982;46(2):162–190. - PMC - PubMed
    1. Olcen P., Kjellander J., Danielsson D., Lindquist B.L. Epidemiology of Neisseria meningitidis, prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis. 1981;13(2):105–109. - PubMed
    1. Caugant D.A., Høiby E.A., Rosenqvist E., Frøholm L.O., Selander R.K. Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis. Epidemiol Infect. 1992;109(2):241–253. - PMC - PubMed
    1. Cartwright K.A.V., Stuart J.M., Jones D.M., Noah N.D. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 1987;99(3):591–601. - PMC - PubMed

MeSH terms